Serum lipids and lipoproteins in patients with endometrial carcinoma receiving adjuvant treatment with hydroxyprogesterone caproate
- PMID: 3885671
- DOI: 10.3109/00016348509154714
Serum lipids and lipoproteins in patients with endometrial carcinoma receiving adjuvant treatment with hydroxyprogesterone caproate
Abstract
Serum levels of triglycerides, total cholesterol, and HDL-cholesterol were determined in 57 patients who were undergoing treatment for stage I endometrial carcinoma. The patients belonged to a clinical trial where group A (control) was treated with surgery plus intravaginal irradiation, whereas group B in addition was treated with hydroxyprogesterone caproate (5000 mg i.m. as a loading dose followed by 1000 mg every 2 weeks for one year). In group B patients followed during the first 13 weeks of treatment, the level of serum triglycerides remained stable, whereas the level of total cholesterol and HDL-cholesterol increased significantly. This increase could not, however, have been caused by the progestogen treatment, as similar changes were seen in group A patients followed for the same period of time. Long-term effects were looked for in patient groups examined 3-12 months after the start of treatment and in groups examined 3-6 months after the hormone therapy was stopped. In neither group could any significant difference in cholesterol or HDL-cholesterol be found. It is concluded that this type of progestogen treatment causes no significant change in the levels of triglycerides, cholesterol, and HDL-cholesterol.
Similar articles
-
Oral contraceptive tablets containing 20 and 30 micrograms of ethinyl estradiol with 150 micrograms desogestrel. Their influence on lipids, lipoproteins, sex hormone binding globulin and testosterone.Acta Obstet Gynecol Scand. 1994 Feb;73(2):136-43. doi: 10.3109/00016349409013416. Acta Obstet Gynecol Scand. 1994. PMID: 8116352 Clinical Trial.
-
Lipid metabolic studies in women with a polycystic ovary syndrome during treatment with a low-dose desogestrel-ethinylestradiol combination.Acta Obstet Gynecol Scand. 1985;64(3):203-7. doi: 10.3109/00016348509155113. Acta Obstet Gynecol Scand. 1985. PMID: 3160212 Clinical Trial.
-
The effect of medrogestone on plasma lipids and lipoproteins in postmenopausal women using conjugated estrogens: an open randomized comparative study.Fertil Steril. 1995 Sep;64(3):525-31. doi: 10.1016/s0015-0282(16)57787-5. Fertil Steril. 1995. PMID: 7641905 Clinical Trial.
-
Life-style and serum lipids and lipoproteins.J Atheroscler Thromb. 2000;7(4):177-97. doi: 10.5551/jat1994.7.177. J Atheroscler Thromb. 2000. PMID: 11521681 Review.
-
The treatment of advanced endometrial cancer with hydroxyprogesterone caproate.Gynecol Oncol. 1974 Aug;2(2-3):377-414. doi: 10.1016/0090-8258(74)90029-8. Gynecol Oncol. 1974. PMID: 4616884 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical